Sequent Scientific Ltd — Quarterly Results & Earnings

₹188.78

+0.00%

Profit Growth YoY504.00%Latest quarter

Sales Growth YoY15.01%Latest quarter

Sales CAGR 5Y5.64%5 year compound

Profit CAGR 5Y-20.72%5 year compound

📋

Quarterly Performance

YoY Profit Growth+504.00%

🔥 Exceptional growth

YoY Sales Growth+15.01%

✅ Strong growth

OPM 5Y Average

Operating profit margin

7.82%

EPS Growth 5Y

-20.84%

Interest Coverage

Higher = safer debt servicing

2.40

ROE

3.21%

ROCE

8.47%

💡

Growth Analysis

Sequent Scientific Ltd reported YoY profit growth of 504.00% and revenue growth of 15.01% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 5.64% and profits at -20.72% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Sequent Scientific Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.